A new study co-led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that the targeted cancer ...

The targeted therapy sunvozertinib was more effective than standard platinum-based chemotherapy as a first-line treatment for patients with advanced non-small cell lung cancer (NSCLC) driven by EGFR ...

Researchers at the University of British Columbia Faculty of Medicine have developed a new targeted cancer therapy that can precisely seek out and destroy tumor cells—showing strong results in ...

Targeted therapies are cancer medications that work more selectively than standard chemotherapy medications. They do this by targeting specific molecules or genetic changes in cancer cells in order to ...

As antibody-drug conjugates move beyond traditional cytotoxic payloads, researchers are rethinking how to make these powerful cancer therapies more precise, more durable, and safer for patients.

Targeted immunotherapy is a new direction in precision cancer therapy, with many approvals for T-cell engagers (TCEs) in hematologic malignancies. The recent approvals of tebentafusp and tarlatamab ...

Nuvalent (NUVL) has secured a U.S. review for its second product in less than a year after the FDA granted priority review for its marketing application targeting the lung cancer therapy neladalkib.

Adults with mantle cell lymphoma who have already failed two or more treatments, including a BTK inhibitor, now have a new ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...